DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 58 · January 2020 DOI: 10.1055/s-009-45326

Deutsche Arbeitsgemeinschaft zum Studium der Leber (GASL)
36. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Mainz, 14.–15.02.2020

Kongresspräsident: Prof. Dr. Peter Galle
Abstracts (HTML) List of Authors
  • 1.4
    Benedé-Ubieto, R; Guo, F; Estévez, O; Woitok, MM; Zheng, K; Asensio, I; Juárez Martín-Delgado, I; Martín-Villa, JM; Vaquero, J; Bañares, R; Liedtke, C; Cubero, FJ; Nevzorova, YA:

    Shedding light on BASH: A novel experimental model of advanced liver damage

  • 1.5
    Wolf, S; Ehlting, C; Häussinger, D; Bode, JG:

    Hepatocytes modify macrophage polarization by reducing the availability of active TGFβ

  • 1.6
    Kaps, L; Choteschovsky, N; Nuhn, L; Klefenz, A; Schuppan, D:

    Nanoparticular bisphosphonate to selectively target and repolarize liver macrophages for anti-fibrotic treatment

  • 1.7
    Sommer, J; Dorn, C; Weiskirchen, R; Hellerbrand, C:

    Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis

  • 1.8
    Hübbers, A; Hennings, J; Lambertz, D; Trautwein, C; Liedtke, C; Sonntag, R:

    Genetic or pharmacological inhibition of cyclin-dependent kinase 2 in Hepatic Stellate Cells acts anti-fibrotic

  • 1.9
    Thangapandi, VR:

    Loss of hepatic Mboat7 leads to liver fibrosis in an inflammation-independent manner

  • 1.10
    Stock, P; Hildebrand, J; Böttcher, G; Christ, B:

    Improved Hepatogenic Differentiation of Human Adipose Tissue-derived MSCs Using a Silicone-based Cell Culture System

  • 1.11
    Wang, S; Peccerella, T; Rausch, V; Mueller, S:

    Hepatic iron overload in alcoholic liver disease: The role of sinusoidal endothelial cells in iron sensing

  • 1.12
    Mueller, J; Rausch, V; Peccerella, T; Elshaarawy, O; Mueller, S:

    The role of PNPLA3 and MBOAT7 during alcohol detoxification: Different mechanisms for fibrosis development

  • 1.13
    Liu, K; Tóth, M; Guo, T; Rose, F; Weiler, SME; Wan, S; Heikenwälder, M; Schirmacher, P; Longerich, T; Breuhahn, K:

    Hippo pathway effectors YAP and TAZ are opponents in the regulation of hepatic fibrosis

  • 1.14
    Smyk, W; Hall, R; Weber, S; Grünhage, F; Lammert, F; Krawczyk, M:

    Common genetic variant c.711A>T in the hepatobiliary phospholipid translocator ABCB4 as risk factor for liver fibrosis

  • 1.15
    Lam, WLM; Gabernet, G; Poth, T; Wolff, K; de Ponti, A; Nahnsen, S; Soborowski, A; Schneller, D; Angel, P:

    RAGE signaling in liver progenitor cells affects fibrosis upon liver injury

  • 1.16
    Hempel, F; Roderfeld, M; Savai, R; Sydykov, A; Irungbam, K; Schermuly, R; Voswinckel, R; Köhler, K; Churin, Y; Kiss, L; Bier, J; Pons-Kühnemann, J; Roeb, E:

    Fibrocytes contribute to TAA-induced liver fibrosis in mice

  • 1.17
    Zimny, S; Wimmer, R; Reiter, FP; Denk, G; Hohenester, S:

    Hydrophobe Gallensäuren wirken durch PI3K-abhängige Proliferation von Sternzellen pro-fibrotisch

  • 1.18
    Xu, F; Gan-Schreier, H; Tuma-Kellner, S; Chamulitrat, W:

    Macrophage-specific Pla2G6 deficiency modulates bone marrow Ly6C levels and APAP liver injury in a sex-dependent manner

  • 1.19
    Hamberger, F; Legchenko, E; Chouvarine, P; Jonigk, D; Manns, MP; Hansmann, G; Mederacke, I:

    Pulmonary arterial hypertension leads to liver fibrosis in the SU5416/hypoxia model in rats

  • 1.20
    González, D; Katharina, R; Hengstler, JG:

    WISP1: A novel extracellular matrix remodeling protein in liver fibrosis

  • 1.21
    Mohamed, MR; Cubero, FJ; Hayback, J; Boekschoten, MV; Davis, RJ; Trautwein, C:

    Absence of JNK activity in hepatocytes exacerbates liver injury and fibrosis during chronic cholestasis in mice

  • 1.22
    NOERENBERG, A; Evenburg, T; Boldt, J; Johannssen, T:

    Expanded primary human liver sinusoidal endothelial cells as a tool for complex hepatotoxicity studies

  • 1.23
    Koenen, MT; Koenen, RR; Caspers, T; Heinzmann, A; Helm, B; Klingmüller, U; Brandt, E; Wirtz, T; Heinrichs, D; Fischer, P; Trautwein, C; Berres, ML:

    Extracellular vesicles from steatotic hepatocytes influence stellate cells in liver fibrosis

  • 1.24
    Gaitantzi, H; Karch, J; Cai, C; Rausch, V; Itzel, T; Teufel, A; Ebert, M; Breitkopf-Heinlein, K:

    BMP-9 modulates the hepatic responses to LPS

  • 1.25
    Yu, L; Chen, C; Wang, S; Peccerella, T; Rausch, V; Mueller, S:

    Role of NOX1 on hepcidin signaling in the crosstalk between macrophages and hepatocytes

  • 1.26
    Hsu, MJ; Christ, M; Christ, B:

    Mesenchymal stromal cells may promote lipid utilization via increment of mitochondria biogenesis in targeted hepatocytes

  • 1.27
    Sturm, L; Roth, L; Zoldan, K; Boettler, T; Huber, JP; Schultheiss, M; Thimme, R; Bettinger, D:

    Blood reelin levels in the progression of chronic liver disease

  • 1.28
    Dai, Z; Song, G; Balakrishnan, A; Yuan, Q; Yang, T; Möbus, S; Weiss, AC; Bentler, M; Bantel, H; Jaeckel, E; Kispert, A; Vogel, A; Saborowski, A; Büning, H; Manns, MP; Cantz, T; Ott, M; Sharma, AD:

    Growth differentiation factor 11 mitigates liver fibrosis via expansion of liver progenitor cells